Physician profile
James B Williams
NPI 1780657056
$6,792.08
in general payments reported to CMS, 2019-2025
35 companies · $1,090 in 2025
The $1,090 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $773 · 2020: $627 · 2021: $1,003 · 2022: $926 · 2023: $1,243 · 2024: $1,130 · 2025: $1,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,463.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $833.28 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $748.48 | 2019-2025 | Farxiga, Wainua, Lokelma |
| E.R. Squibb & Sons, L.L.C. | $677.39 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $605.89 | 2019-2025 | |
| Boston Scientific Corporation | $577.78 | 2021-2025 | Vigilant X4 Crt-D, Accolade Sr, Latitude Communicator Power Supply |
| Merck Sharp & Dohme LLC | $575.42 | 2021-2025 | Verquvo, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $545.53 | 2019-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $381.04 | 2020-2025 | Amvuttra, Onpattro |
| Pfizer INC. | $364.98 | 2019-2025 | |
| Shockwave Medical, INC | $215.24 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $196.32 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $120.27 | 2019-2024 | Lifevest |
| Amgen INC. | $114.58 | 2022-2025 | Repatha |
| Lundbeck LLC | $112.28 | 2024 | Vyepti |
| Bridgebio Pharma, INC. | $95.36 | 2025 | Attruby |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $93.27 | 2021-2024 | Onyx Frontier |
| Novo Nordisk INC | $72.20 | 2024 | Wegovy |
| Angiodynamics, INC. | $50.37 | 2024-2025 | Auryon Laser System 100-120 Vac |
| W. L. Gore & Associates, INC. | $46.18 | 2021-2025 | Gore Cardioform Septal Occluder |
| Lexicon Pharmaceuticals, INC. | $42.49 | 2023-2024 | Inpefa |
| Kestra Medical Technology Services, INC. | $36.32 | 2025 | Assure Wcd |
| Scpharmaceuticals INC. | $34.13 | 2024 | |
| Ambu INC. | $33.22 | 2025 | |
| Terumo Medical Corporation | $30.55 | 2021-2023 | Glidewire |
| Bayer Healthcare Pharmaceuticals INC. | $25.77 | 2025 | |
| Glaxosmithkline, LLC. | $25.06 | 2025 | Shingrix |
| Bard Peripheral Vascular, INC. | $20.49 | 2023 | Rotarexs 6 F X 135 Cm |
| Portola Pharmaceuticals, LLC | $17.72 | 2020 | |
| Abbott Laboratories | $17.33 | 2021 | |
| Impulse Dynamics (USA) INC. | $16.43 | 2023 | Optimizer |
| Philips North America LLC | $14.79 | 2025 | Azurion 7 M20 |
| Corcept Therapeutics | $14.73 | 2025 | Korlym |
| Cardiovascular Systems INC. | $14.50 | 2023 | Diamondback Coronary |
| Chiesi USA, INC. | $11.39 | 2021 | |
| Preventice Services, LLC | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.